Infectious Disease Weekly Digests
AI-curated weekly summaries of top research in Infectious Disease. 12 digests published.
2026-W24 · Jul 22, 2026
This Week in Infectious Disease: PrEP Awareness and Antibiotic Efficacy
From the Journal of the International AIDS Society, a meta-analysis examined disparities in pre-exposure prophylaxis awareness among men who have sex with men [1]. The study identi…
2026-W25 · Jul 22, 2026
This Week in Infectious Disease: Antimicrobial Resistance Trends and Clinical Prophylaxis
This week’s research highlights diverse perspectives on public health, ranging from clinical interventions to the ecological drivers of resistance. In a meta-analysis published in …
2026-W26 · Jul 22, 2026
This Week in Infectious Disease: Pediatric Pneumonia Risk Scores and Antimicrobial Resistance
Research regarding pediatric outcomes highlighted the continued utility of established diagnostic standards. In a secondary analysis published in medRxiv, researchers evaluated fiv…
2026-W27 · Jul 22, 2026
This Week in Infectious Disease: Tuberculosis Treatment Regimens and Antimicrobial Resistance Trends
Research this week highlighted developments in the management of pulmonary rifampicin-resistant tuberculosis. In The New England Journal of Medicine, a Phase 3 randomized controlle…
2026-W28 · Jul 22, 2026
This Week in Infectious Disease: Antimicrobial Stewardship and Antiviral Treatment Dynamics
Clinical management of multidrug-resistant infections saw significant scrutiny this week regarding optimal treatment pathways. In the International journal of antimicrobial agents,…
2026-W30 · Jul 22, 2026
This Week in Infectious Disease: HIV Management Strategies and Antimicrobial Stewardship
Research this week highlighted various approaches to managing chronic infections, particularly regarding HIV. In the journal HIV medicine, a pooled analysis of Phase 3/3b trials re…
2026-W19 · Jun 4, 2026
This Week in Infectious Disease: HIV Lipid Management and Sepsis Care
From the New England Journal of Medicine, a trial examined pitavastatin versus placebo in people with HIV aged 40 to 75 years on stable antiretroviral therapy [1]. The study found …
2026-W22 · Jun 4, 2026
This Week in Infectious Disease: Microbiome Therapies and Antibiotic Resistance
This week's research highlights emerging strategies for managing inflammatory conditions and addressing antimicrobial challenges. From the New England Journal of Medicine, a trial …
2026-W23 · Jun 4, 2026
This Week in Infectious Disease: HIV Retinitis and Microbiome Research
From the New England Journal of Medicine, a trial reported that pooled cytomegalovirus retinitis prevalence is 3% among people with HIV in sub-Saharan Africa [1]. This systematic r…
2026-W18 · Apr 27, 2026
This Week in Infectious Disease: COVID-19 Treatments and Tuberculosis
From the New England Journal of Medicine, a trial examined the efficacy of metformin, fluvoxamine, or ivermectin versus placebo for non-hospitalized adults with SARS-CoV-2 infectio…
2026-W17 · Apr 23, 2026
This Week in Infectious Disease: HIV Prevention and H. pylori Eradication
From the New England Journal of Medicine, a trial involving 9,289 critically ill patients across 26 ICUs in Australia and Canada evaluated Selective Decontamination of the Digestiv…
2026-W16 · Apr 15, 2026
This Week in Infectious Disease: HIV Treatments and Vaccine Safety
From the New England Journal of Medicine, a trial reported that nevirapine plus lamivudine and zidovudine improved lymphocyte counts and reduced adverse effects compared to efavire…